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Summary.-Analysis oftime-lapse cinematographic film permitted the construction
of pedigrees from 88 well oxygenated cells of a mouse osteosarcoma (MOS). These
cells have been chronically treated with various concentrations of the hypoxic cell
sensitizer misonidazole (MIS) over periods of up to 96 h.
At concentrations of 0-5 and 1 mm there is a 2-3 h increase in cell-cycle time. Con-
centrations of 2 mm show an intermitotic time delay of 7.6-10.3 h. At 4 mm cells
divided only once.
With increasing drug concentration there was an increase in the number of
abnormal mitoses. These results were compared with cloning efficiency (PE) experi-
ments. PE at 0-5 mm is 80%, at 1 mm40% and at 2 mm is reduced to 4%.
Cells treated with 2mM MIS over a period of28-6 h resume their normal cycle when
the drug is washed from the culture. This may indicate that DNA is not a major
target for MIS. It is concluded that this hypoxic cell sensitizer is also toxic for MOS
cells in well oxygenated conditions.
IT IS generally accepted that many
human tumours contain hypoxic regions.
Local failure in radiotherapy is assumed
in some of the cases to be due to hypoxic
but viable cells present in such tumours.
Experimental animal studies have demon-
strated that viable, non-cycling cells in
these hypoxic regions can indeed limit the
probablity of cure by X-rays.
Various approaches have been investi-
gated to eliminate the influence ofhypoxic
cells on tumour responses, for instance
high LET irradiation (Dutreix & Tubiana,
1979) and hyperbaric oxygen (Churchill-
Davidson, 1966).
A third and promising approach to the
problem ofeliminating the effect oftumour
hypoxia is the use of hypoxic cell sensi-
tizers (Adams, 1973).
One of them, misonidazole (MIS), has
been investigated extensively in vivo and
in vitro, and was characterized as an
oxygen mimetic in respect of its ability to
sensitize hypoxic cells to X-rays (Sheldon
et al., 1974). Its cytotoxic effect is de-
pendent on temperature, drug concentra-
tion and contact time. Furthermore, it
was reported not to affect the radio-
sensitivity of well oxygenated cells
(Asquith et al., 1974). MIS therefore
seemed to be most promising for clinical
use.
There is evidence however that treat-
ments with this drug alone or in com-
bination with radiotherapy have an ad-
verse effect on normal tissues. Varying
degrees ofdamage, ranging from reversible
peripheral neuropathy to an organic
psychosyndrome, have been found (Dische
et al., 1977, 1978; Jentzsch et al., 1977).
Toxic effects ofMIS on hypoxic cells in
vitro have been reported. This toxicity
could be responsible for a possible
increased therapeutic effectiveness. A
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preferential cytotoxicity for hypoxic over
oxygenated cells was demonstrated by
several authors (Roizin-Towle & Hall,
1975; Adams et al., 1976; Brown, 1977;
Taylor & Rauth, 1977; Pettersen, 1978;
Yuhas & Li, 1978; Wong et al., 1978).
However, in vitro studies on the toxicity
of clinical doses of MIS under conditions
of prolonged incubation have shown that
there is also a slight effect on well oxygen-
ated cells (Stratford & Adams, 1977;
Sridhar & Sutherland, 1977).
Inradiotherapeutic treatments, patients
are receiving multiple daily doses of
radiation and drugs. In such treatment
schedules the concentration of MIS in the
tumour may be maintained at an effective
level for extended periods of time, since it
is known that the half-life of removal in
man is 10-18 h (Dische et at., 1977). We
may assume that well oxygenated cells
from normal tissues will be exposed to
similar drug concentrations. It is therefore
ofimportance to study the toxic effects of
various concentrations ofMIS on oxygen-
ated cells through several cell generations.
Time-lapse cinematography provides the
possibility of studying the fate of treated
and untreated individual cells and their
offspring.
In this paper we report cinematographic
data on the effect of MIS on the repro-
ductive capacity of cultured cells, on
changes in cell-cycle time as a function of
the concentration of MIS, and on the
frequency of abnormal mitoses in succes-
sive generations.
MATERIALS AND METHODS
Cells and culture conditions
The MOS cell line in culture originated in
1973 from a spontaneous osteosarcoma in the
tibia of a BALB/c mouse. Characteristics of
this line have been published (Deys &
Barendsen, 1975). Stock cultures were main-
tained in monolayer cultures on Costar tissue
culture flasks at 37°C in a humidified CO2
incubator (2% CO2 in air). Cells were culti-
vated in Eagle's MEM supplemented with
10% foetal calf serum, glutamine and peni-
cillin. Under these conditions, cells in
asynchronous exponential growth have an
average cell doubling time of 9-7 h.
Misonidazole, Ro-07-0582 (2-nitro-1-imid-
azoly)-3-methoxy-2-propanol (MIS) was made
available by Dr Lenox-Smith of Roche
Products Ltd. The drug was dissolved in
medium at a concentration of 5 mm and
diluted as needed for experiments.
Assayfor colonyformation
(a) For toxicity tests under prolonged expo-
sure, variousaliquots ofexponentiallygrowing
MOS cellswere plated inmacroplates (Greiner
635TC). In addition to a control culture, 4
experimental concentrations have been used:
0 5, 1, 2 or 4 mm of MIS dissolved in fresh
growth medium. Plates were placed at 37°C
in a CO2 incubator, and after 6 days were
fixed and Giemsa-stained.
Survival was assayed as the ability of the
cells to form colonies of more than 50 cells.
Surviving fractions were calculated relative
to controls and presented as a function ofthe
drug concentration.
(b) Short-term toxicity was tested by
cultivating MOS cells in 0 5 or 2mM MIS for
a period of 20 h. Cells were then plated and
further treated as under (a).
(c) The possible degradation of the drug
MIS in the medium over periods up to 96 h
was tested as follows:
Two groups of 10 flasks were placed in the
CO2 incubator at 37°C, one series containing
2mM MIS in MEM, the other with MEM but
no drug. After 0, 24, 48, 72 and 96 h respec-
tively, a flask from each group received a
known number of MOS cells. Cultures were
fixed after 6 days and colonies of more than
50 cells were counted.
Assayfor cellproliferation
(a) Time-lapse cinematography.-A Leicina
special camera with an automated timing unit
was attached to an inverted phase-contrast
microscope (Leitz diavert) placed in a light-
tight box maintained at controlled tempera-
ture.
A field of vision of 0 7 mm2 was photo-
graphed using a 10 x phase-contrast objec-
tive. The light source was a Leitz Mecablitz
181 flashgun. Kodachrome 40 films were used
and were processed by Kodak. Films were
analysed with an HKS viewer attached to a
frame counter, and family trees could be
traced frame by frame.
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(b) Culture conditions.-For time-lapse
cinematography, 4 x 104 cells in proliferative
phase were plated in a 25cm2 Costar flask,
Cat. No. 3050, in 5ml medium. Cultures were
returned to the incubator for 24 h to achieve
pH adjustment of the medium and to allow
the cells to attach. The culture was then
placed under the film unit and a field was
selected so that 3-6 uniformly spaced cells
could be photographed. After 24 h, in the case
of MOS cells corresponding to about 2 cell
generations, medium was changed. This
medium contained 0, 0-5, 1, 2 or 4 mM of
MIS. In another set of experiments cells were
grown in MEM with 2 mm ofMIS for a period
of 28-6 h only, after which the drug was
washed from the flask. The cells were photo-
graphed before, during and after treatment
with MIS in all experiments.
Filming and analysis
A frame interval of 3 min over periods up
to 96 h was used. This observation period was
chosen to study 7 generations, 2 before treat-
ment and 5 during treatment. Every com-
pleted generation cycle was measured, i.e.
onlythose interphases that were preceded and
followed by a successful mitosis were in-
cluded.
Unsuccessful mitoses ("trials") or abnormal
mitoses (multipolar mitoses, giant cell forma-
tions, rounded cells that showed no evidence
of mitotic cleavage within 30 h) were scored
separately.
Mitotic cells whose daughter cells fused
were scored as abnormal divisions. The fused
product was only scored as normal if it led to
another mitosis. Cells migrating into or out of
the field were not analysed.
RESULTS
Assayfor colonyformation
(a) Aerobic MOS cells, continuously
exposed to various concentrations of
MIS, showed a drug-concentration-de-
pendent curve for plating efficiency (PE).
With increasing concentrations of the
drug the surviving fraction decreased
exponentially (Fig. 1).
Concentrations up to 0 3 mm induced
no significant decrease in PE. Between
0 3 and 2 mm a decrease in reproductive
capacity could be seen and the clones
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FIG. 1. Survival curve of well oxygenated
MOS cellsexposed to various concentrations
ofMIS for 6 days.
became smaller with higher concentra-
tions of the drug. At a concentration of
3 mM no clones were present.
(b) A treatment with 0 5mM or 2mM
MIS for 20 h had no measurable effect on
viability. A PE of 100% was obtained in
both cases.
(c) Aerobic MOS cells, exposed to a dose
of2mMMISin mediumthat hadpreviously
been kept in a CO2 incubator for up to
96 h, showed no change in the toxicity of
the drug. We conclude that there is no
measurable degradation of the drug under
our experimental conditions.
Assay ofcellproliferation
The progenies of 65 treated and 23
untreated cellshave been studiedbymeans
of time-lapse cinematography on 11 films
to construct their pedigrees.
(a) Cells in cultures without MIS.-The
average cell-cycle time varies with the
generation (Fig. 2). Before the medium
change, cells exhibit an average inter-
mitotic time of 11 h. A medium change
induced a slight prolongation of the cycle
of untreated cells, but in the next genera-
tion the cell-cycle time decreased to an
average of 9.5 h. The 3rd and 4th genera-
tion after medium change showed a slight
increase in cycle time. From other film
data, where a significant increase was
regularly observed, it is suggested that
this longer cycle time is connected with an
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FIG. 2.-Comparison of cell-cycle times of
untreated MOS cells (O-- - O) and cells
treated with 2mM MIS (M---0). Treat-
ment started during the 2nd mitotic cycle
and was terminated 28-6 h later (in the 5th
mitotic cycle).
increase in density of cultures (Deys, un-
published).
Before treatment with the drug, all cells
were allowed to go through 2 cell cycles.
From Fig. 3 it can be seen that a mean
generation time of 11.0 h with a standard
deviation of 1-5 h could be obtained for
these cells. This mean value is consistent
with the cell-cycle time calculated from a
growth curve of log-phase cells and from
clone-size distribution data measured as a
function of the time after plating (Deys,
unpublished). The light flux of the flash-
gun, with intervals of 3 min, has no
detectable effect on the cell cycle. Under
these conditions the cells within the field
of vision may be considered to be repre-
sentative of the whole population of the
culture.
(b) Treatment of prolonged duration.-
A30 h
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FIa. 3.-Comparison of cell-cycle times of
MOS cells treated with 05 mM (U), 1 mM
(*), 2 mm (0) or 4 mM (0) MIS. Treat-
ment started during the 2nd mitotic cycle
and was continued throughout the experi-
ment.
(i) Intermitotic time. For most experi-
ments at various concentrations ofMIS, an
increase of intermitotic time was observed
during the generation in which MEM was
replaced by MIS in MEM (Fig. 3). Except
for 2mM MIS this delay is 1-2 h longer
than the delay in control cells due to the
change of medium (see (a)).
Cells at subsequent generations, treated
with drug concentrations of 0-5 and 1 mm,
showed an increase in intermitotic time
of 2-3 h, and at concentration of 2mM
MIS there was a delay of between 7-6 and
10'3 h.
At the drug concentration of 4 mm the
cells divided only once. They seemed
unable to complete the next cycle afterthe
start oftreatment.
(ii) Cellular morphology and abnormal
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FIG. 4.-Percentage of abnormal mitoses in
successive generations of MOS cells treated
with 1 mm (*), 2 mm (0) or 4 mM (0) MIS.
mitoses. At 4 mm, at which cells failed to
divide for a second time after the start of
treatment, they remained motionless, did
not proceed into second mitosis, and in
several cases became giant cells. The
spindle-shaped MOS cells lost their
characteristic morphology and flattened
out. Pycnosis was not seen. In cases where
fusion of 2 cells occurred it was always
between sister cells. Up to 14% of mitoses
directly after treatment were scored as
abnormal (Fig. 4). Where during the next
generation mitotic figures were seen they
were always abnormal.
At 2 mm up to 18% of the mitoses were
aberrant. In successive generations the
frequency of abnormal divisions decreased
gradually to about 5%. Changes in cell
shape could not be clearly seen at this
concentration.
At 1 mm a slight increase in mitotic
failure occurred during the second and
third generation after the start of treat-
ment, but at 0-5 mm no such aberrations
were seen (Fig. 4).
(c) Treatment of short duration.-Cells
have been treated with a dose of 2mM
MIS for 28-6 h. These cells display a pro-
longed cycle time during treatment, and
go through 1-3 cell cycles. Successive
generation times directly after treatment
returned immediately to normal values,
when the medium was changed. Offspring
of treated cells behaved as if they had
been untreated over the next 3 mitotic
cycles (Fig. 2).
DISCUSSION
The results described in this paper show
that continuous exposure to MIS for up to
96 h causes significant effects on MOS cells
in log-phase cultures. The prolongation of
the cell cycle is in excess of 36 h at 4 mM,
7-5-10-4 h at 2 mM, 2-3 h at 1 and 0 5 mM
of MIS in the culture medium. Further-
more, in various generations during ex-
posure to MIS, up to 18% abnormal
mitoses are found at 2 mm and up to 4%
at 1mM. In the continuous presence of
MIS the clonogenic capacity was reduced
to about 80% at 0-5 mm, to 40% at 1 mm
and to 5% at 2 mM.
These findings are of interest in the
interpretation of adverse effects of MIS
after its administration to patients with
cancer (Dische et at., 1978). Because of a
relatively long half-life ofMIS in man, and
the fractionated applications of the drug
with intervals of one day, the levels of
MIS in plasma can be close to 0-5 mm.
This concentration is known to cause a
number of side effects. On the basis of
clinical data it has been suggested that
total doses in excess of 300 mg/kg MIS
should not be given (Dische et al., 1977).
Several studies of the toxicity of MIS
for cells under oxic conditions have been
carried out for exposures of limited dura-
tion. As a consequence of this short ex-
posure, they have shown at doses of up to
5 mM no damage to cell proliferative
capacity measured as PE. In our data,
however, with well oxygenated cells grow-
ing under continuous exposure to MIS at
a level as low as 0 5 to 1 mm, definite
effects on cell-cycle times were found.
Since our experimental data show no
deterioration of the drug over periods of
96 h, we know that our cells have been in
these conditions for at least 4 generations.
Secondly, abnormal mitoses and an im-
paired capacity for cloning was found. If
such a decreased cell production applies to
cells in normal tissues, which may depend
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for their integrity and function on rapid
cell renewal, the population deficit caused
by the drug might be responsible for the
toxicity found in some normal tissues,
e.g. gut. Evidently the responses of cul-
tured cells described in this paper provide
no insight into the neurotoxic effects of
MIS in patients.
With respect to the relation between
published data on in vitro cytotoxicity of
MIS and our own evidently different re-
sults, several other aspects are worth
mentioning. The cytotoxic effects are
dependent on the cell line (Taylor &
Rauth, 1977). Our data have been ob-
tained with the MOS cell line. We have
evidence from preliminary data on im-
pairment of the clonogenic capacity by
MIS of another cell line, RUC-2. This line
was derived from a ureteric carcinoma in a
rat (Deys & Barendsen, 1975). The sensi-
tivity of this line to MIS is a factor of
about half that for the MOS cell line.
It has clearly been pointed out that
electron-affinic radiosensitizers may act by
more than one mechanism. A direct effect
on cellular DNA, as suggested by Palcic &
Skarsgard (1978), seems unlikely. In
similar experiments with various cell lines
by Hall and ourselves, there were no
visible chromosomal aberrations when
cells were treated with toxic doses of MIS
(Hall et al., 1977; Deys, unpublished). We
were also unable to induce sister-chrom-
atid exchanges with this drug (Deys,
unpublished).
Finally, our observation of a rapid re-
turn ofinter-mitotic times to normal after
removal of the drug might be considered
as an additional indication that the dam-
age to the proliferative capacity is either
quickly repaired or is not maintained at all
in subsequent generations. This might
imply that DNA is not the primary target
for the drug cytotoxicity.
We conclude that both hypoxic and
well oxygenated cells can be damaged by
the hypoxic cell sensitizer MIS, but data
in the literature show that the drug acts
more rapidly and at lower concentrations
on hypoxic than on oxic cells.
We thank Professor J. F. Fowler for suggesting
these experiments, Professor G. W. Barendsen for
discussions and Dr Lenox-Smith (Roche, Ltd) for
supplying the drug.
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